A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207
Michelle A. Kendall, Janet W. Andersen, Charles van der HorstVolume:
27
Year:
2006
Language:
english
Pages:
295
DOI:
10.1016/j.cct.2006.02.001
File:
PDF, 114 KB
english, 2006